Quince Therapeutics Inc (NAS:QNCX) Stock News, Headlines & Updates
Quince Therapeutics Inc Stock News from GuruFocus
- 1
Jun 25, 2024
Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia
Business Wire • 7:00am
Jun 03, 2024
Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
Business Wire • 7:00am
May 13, 2024
Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Business Wire • 7:00am
May 06, 2024
Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
Business Wire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news